Reuters logo
BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​
2017年10月31日 / 上午11点17分 / 22 天前

BRIEF-Thermo Fisher enters agreement with Blueprint Medicines​

Oct 31 (Reuters) - Thermo Fisher Scientific Inc

* Thermo Fisher Scientific Inc - ‍ expanded development of Oncomine Dx Target Test by entering into an agreement with Blueprint Medicines Corporation​

* Thermo Fisher Scientific - co will retain rights to commercialize test globally, to lead necessary filings to seek clearance from regulatory agencies

* Thermo Fisher Scientific Inc - ‍agreement to develop and commercialize Oncomine Dx Target Test as a companion diagnostic for BLU-667​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below